Early Stage Follicular LymphOma and RadioTherapy PLUS Anti-CD20 Antibody
Early Stage Follicular LymphOma and RadioTherapy PLUS Anti-CD20 Antibody
Recruiting · NCT05045664 · Registry updated 2026-04-28Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Early Stage Follicular LymphOma and RadioTherapy PLUS Anti-CD20 Antibody | Early Stage Follicular Lymphoma WHO Grade 1/2 or 3a | Recruiting | Phase 3 | 2026-04-28 | NCT05045664 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Heidelberg University | 49 |
12 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Katharinen Hospital Stuttgart | Stuttgart | Germany | 1 |
| Krankenhaus Barmherzige Brüder | Regensburg | Germany | 5 |
| LMU München | Munich | Germany | 1 |
| Strahlentherapie KH Maria Hilf | Mönchengladbach | Germany | 1 |
| Technische Universität München | Munich | Germany | 1 |
| University Hospital Heidelberg | Heidelberg | Germany | 19 |
| University of Essen | Essen | Germany | 2 |
| University of Göttingen | Göttingen | Germany | 1 |
| University of Rostock | Rostock | Germany | 3 |
| University of Tübingen | Tübingen | Germany | 2 |
| University of Ulm | Ulm | Germany | 3 |
| Vivantes Klinikum Berlin | Berlin | Germany | 1 |